Sequential Estrogen-Progestin Addition to Gonadotropin-Releasing Hormone Agonist Suppression for the Chronic Treatment of Ovarian Hyperandrogenism: A Pilot Study
December 1994
in “
The Journal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism
”
gonadotropin-releasing hormone agonist GnRH agonist transdermal estradiol estradiol patches medroxyprogesterone acetate testosterone androstenedione hirsutism hair diameter polycystic ovary syndrome PCOS withdrawal bleeding breakthrough bleeding menopausal symptoms bone mineral content GnRH agonist estradiol patches medroxyprogesterone acetate testosterone androstenedione hirsutism hair diameter PCOS withdrawal bleeding breakthrough bleeding menopausal symptoms bone mineral content
Studysummary This study concluded that a regimen of transdermal estradiol and oral medroxyprogesterone acetate effectively reduces hirsutism while minimizing side effects in women with polycystic ovary syndrome.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on academic.oup.com →